VRC-01-producing anti-HIV genetic vaccine therapy (Immusoft/Seattle Biomedical Research Institute)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameVRC-01-producing anti-HIV genetic vaccine therapy (Immusoft/Seattle Biomedical Research Institute)
Drug Alias NameB-cell gene therapy (Immusoft)VRC-01-producing anti-HIV gene therapy (Immusoft)antibody-producing anti-HIV gene therapy (Immusoft)VRC-01-producing anti-HIV lentiviral pseudotype-based genetic vaccine therapy (Immusoft/Seattle Biomedical Research Institute)
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmusoft Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmusoft CorpCenter For Infectious Disease Research
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A